Akso Health (AHG) Price to Sales (2017 - 2019)

Akso Health (AHG) has reported Price to Sales for 3 consecutive years, with 16.57 the latest figure, recorded in Q3 2019.

• For the quarter ending Q3 2019, Price to Sales fell 84.12% year-over-year to 16.57; the trailing twelve-month figure through Sep 2019 stood at 4.85 (up 61.98% YoY), and the FY2026 full-year result was 46.98, up 106.44% from the prior year.
• Price to Sales slipped to 16.57 in Q3 2019 per AHG's latest filing, from 23.81 in the prior quarter.
• Across five years, Price to Sales topped out at 104.36 in Q3 2018 and bottomed at 9.34 in Q2 2018.
• Historically, Price to Sales has averaged 35.88 across 3 years, with a median of 21.73 in 2018.
• The sharpest annual moves came in 2018 and 2019: Price to Sales jumped 472.88% in 2018, then sank 84.12% in 2019.
• Over 3 years, Price to Sales stood at 10.95 in 2017, then surged by 472.88% to 62.73 in 2018, then plunged by 73.59% to 16.57 in 2019.
• According to Business Quant data, Price to Sales over the past three periods registered 16.57, 23.81, and 39.63 for Q3 2019, Q2 2019, and Q1 2019 respectively.